Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines. - Wikidata - wikimedia - TriplyDB

Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines.

Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines.

http://www.wikidata.org/entity/Q38076053

about

A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy Current status of autologous breast tumor cell-based vaccines.Overexpressed oncogenic tumor-self antigens Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide.Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist.Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors Harnessing the immune system for the treatment of breast cancer.Influenza virosomes as vaccine adjuvant and carrier system.Suitable trial designs and cohorts for preventive breast cancer agents.Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines.Immunotherapy for breast cancer: past, present, and future.Improvement of Antitumor Therapies Based on Vaccines and Immune-Checkpoint Inhibitors by Counteracting Tumor-Immunostimulation.

P2860

Q26824462-72C5B656-E8D6-4881-8995-6EE705E8F141 Q35154214-BE3A073D-1C88-4E92-AE63-6657B3F027EE Q35886756-C7BA021E-396E-4FEA-89DF-027F37F625BB Q36276014-EB67F761-D754-462C-8F2A-0ABF66B081F4 Q36777133-01B75349-138D-4467-A6D2-7900A4E4EDA9 Q37078941-AD56D2FC-3709-460B-83EE-CAA938880947 Q37476039-B97BA31A-BF2E-4C45-AD72-8E99EC88BAC8 Q38124062-E440EBC7-F84B-472C-AEB9-DD48803D7B57 Q38150222-DC19094B-1B8F-4F1F-81A2-B10B70E21FD1 Q38215394-7D3ABC11-652E-4699-927B-3FE7C9E860A1 Q38787696-491EE59A-B35E-4711-A821-AD0B5A6C8B71 Q49872011-3E6C2E03-7971-4E70-8DD7-4A8470EFCF2A

P2860

Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines.

http://www.wikidata.org/entity/Q38076053

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Vaccination for the prevention ...... on Her-2/neu peptide vaccines.

@en

type

label

Vaccination for the prevention ...... on Her-2/neu peptide vaccines.

@en

prefLabel

Vaccination for the prevention ...... on Her-2/neu peptide vaccines.

@en

P1433

Q38076053-58ADB680-C01F-444C-B178-594940AC2697

P1476

Q38076053-DAA0CB90-8FE0-4A63-8558-767F13F5DDC6

P2093

Q38076053-C3133528-B78B-42AF-8072-C700D45B8CCF

Q38076053-D6DC5368-94BD-4840-AADA-4340169C91AE

P2860

Q38076053-02255417-4851-418B-8BC0-F5FCA05E2521

Q38076053-058224AC-68B3-4C94-8507-A9ACBA573F56

Q38076053-0585B0E1-777C-4F49-80B5-5890DDE9157C

Q38076053-062DD7F7-98FF-41D8-8914-B04FDAE196A6

Q38076053-0926D90C-F1C7-4010-9306-579D12E93177

Q38076053-0C2E55D6-2C93-4ED0-9DED-BE35BB2C38BF

Q38076053-170B59DA-12A7-490D-A809-A30D85246E4E

Q38076053-197FDECE-5F9A-42B5-9E45-8664EE82554A

Q38076053-1C31CA0B-BE35-4184-A9E9-05A1D2088AB7

Q38076053-202FA7D6-D43B-4867-97D8-F597181089AA

P2888

Q38076053-C645C463-24F9-4D93-B35E-F8EC3EB71973

P304

Q38076053-AC35DEE4-DD7E-4E3F-8397-53D28E7FA0FC

P31

Q38076053-C2CE149B-D109-4632-B4C6-4705EDE26FFA

P356

Q38076053-6ECEB5A9-120A-434A-8B43-D241AE94F355

P407

Q38076053-67A8B5E3-CE05-46AF-B7D3-D9FEEEFEFCF6

P433

Q38076053-1CC55AEE-D186-4404-AD2C-80BCD544FAC1

P478

Q38076053-6FB9D972-0900-47A1-BD7C-452EEEA0DAB0

P50

Q38076053-77F20B81-F203-4003-9B11-E3937C85C49D

P577

Q38076053-0838FF11-4E12-4FEA-85EA-0DC57B31C782

P6179

Q38076053-4FD4BB37-4BA1-4AAB-80FB-5B2124848DBF

P698

Q38076053-5FDE4B02-43F5-4A32-A4BD-77EEB4F74032

P356

S10549-013-2410-8

P1433

Breast Cancer Research and Treatment

P1476

Vaccination for the prevention ...... on Her-2/neu peptide vaccines

@en

P2093

Adam B Davis

http://www.w3.org/2001/XMLSchema#string

Christoph C Zielinski

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

The changing global patterns of female breast cancer incidence and mortality

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors

Vaccines for tumour prevention

Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

P2888

s10549-013-2410-8

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-013-2410-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1052877071

http://www.w3.org/2001/XMLSchema#string

P698

23340862

http://www.w3.org/2001/XMLSchema#string